GLPBio

MAPK Signaling

Research Areas

Products Related to MAPK Signaling(660)

  • GC44530 structure
    GC44530p38 MAPK Inhibitor
    CAS: 219138-24-6
    Purity: >98.00%

    p38 MAPK inhibitor is a potent inhibitor of p38 MAP kinase (IC50 = 35 nM).

  • GC44587 structure
    GC44587PDMP (hydrochloride)
    CAS: 73257-80-4
    Purity: >98.00%

    PDMP is a ceramide analog first prepared in a search for inhibitors of glucosylceramide synthase.

  • GC44653 structure
    GC44653PKA Inhibitor (5-24)
    CAS: 99534-03-9
    Purity: >98.50%

    El inhibidor de PKA (5-24) es un inhibidor peptÍdico sintético, competitivo y potente de la PKA (proteÍna quinasa dependiente de AMPc), con una Ki de 2,3 nM.

  • GC44673 structure
    GC44673PQ-10
    CAS: 927691-21-2
    Purity: >98.00%

    PQ-10 es un potente inhibidor de la fosfodiesterasa 10A (PDE10A) con IC50 y ED50 de 4,6 nM y 13 mg/kg, respectivamente.

  • GC44852 structure
    GC44852Rp-8-bromo-Cyclic AMPS (sodium salt)
    CAS: 925456-59-3
    Purity: >98%

    Rp-8-bromo-Cyclic AMPS (Rp-8-bromo-cAMPS) is a cell-permeable cAMP analog that combines an exocyclic sulfur substitution in the equatorial position of the cyclophosphate ring with a bromine substitution in the adenine base of cAMP.

  • GC44853 structure
    GC44853Rp-8-CPT-Cyclic AMP (sodium salt)
    CAS: 221905-35-7
    Purity: >98.00%

    Rp-8-CPT-Cyclic AMP (sal de sodio), un anÁlogo de cAMP, es un antagonista potente y competitivo de la activaciÓn inducida por cAMP de PKA I y II dependiente de cAMP.

  • GC44917 structure
    GC44917Sorafenib N-oxide
    CAS: 583840-03-3
    Purity: >98.00%

    Sorafenib N-oxide is an active metabolite of sorafenib, an inhibitor of Raf-1, B-RAF, and receptor tyrosine kinases.

  • GC44920 structure
    GC44920Sp-8-bromo-Cyclic AMPS (sodium salt)
    CAS: 1573115-90-8
    Purity: >98.00%

    Sp-8-bromo-cyclic AMPS (Sp-8-bromo-cAMPS) is a cell-permeable, cAMP analog that combines an exocyclic sulfur substitution in the axial position of the cyclophosphate ring with a bromine substitution in the adenine base of cAMP.

  • GC45064 structure
    GC45064Tomatidine (hydrochloride)
    CAS: 6192-62-7
    Purity: >98.00%

    La tomatidina (clorhidrato) actúa como un agente antiinflamatorio al bloquear la señalización de NF-κB y JNK.

  • GC45067 structure
    GC45067Tpl2 Kinase Inhibitor
    CAS: 871307-18-5
    Purity: >95.00%

    Tpl2 Kinase Inhibitor (TKI) es un compuesto de naftiridina permeable a las células que actúa como un potente inhibidor reversible y competitivo de ATP de Tpl2 kinase

  • GC45099 structure
    GC45099U-0126
    CAS: 109511-58-2
    Purity: >98.00%

    Un inhibidor de MEK

  • GC45902 structure
    GC45902Trametinib-13C-d3
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC46015 structure
    GC46015KY 05009
    CAS: 1228280-29-2
    Purity: >99.50%

    KY 05009 es un inhibidor de la cinasa que interactúa con Nck y Traf2 competitivo con ATP (TNIK) con una Ki de 100 nM. KY 05009 inhibe farmacológicamente la transición epitelial a mesenquimatosa (EMT) inducida por TGF-β1 en células de adenocarcinoma de pulmón humano. KY 05009 inhibe la expresión proteica de TNIK y la actividad transcripcional de los genes diana Wnt e induce la apoptosis en las células cancerosas. KY 05009 ejerce actividad anticancerígena.

  • GC46123 structure
    GC46123Comprehensive Kinase Screening Library
    Purity: >98.00%

    For screening of a variety of kinase inhibitors

  • GC46554 structure
    GC465542'-O-Monosuccinyladenosine-3',5'-cyclic monophosphate
    CAS: 36940-87-1
    Purity: >98.00%

    2'-O-Monosuccinyladenosine-3',5'-el monofosfato cÍclico es un anÁlogo de AMPc que puede acoplarse covalentemente a la acetilcolinesterasa.

  • GC46808 structure
    GC46808ADTL-EI1712
    CAS: 2414916-45-1
    Purity: >98.00%

    A dual ERK1 and ERK5 inhibitor

  • GC47045 structure
    GC47045Carvedilol-d5
    CAS: 929106-58-1
    Purity: >99.00%

    An internal standard for the quantification of carvedilol

  • GC47088 structure
    GC47088Cilostazol-d4
    CAS: 1215541-47-1
    Purity: >99.00%

    An internal standard for the quantification of cilostazol

  • GC47166 structure
    GC47166Dabrafenib-d9
    CAS: 1423119-98-5
    Purity: >99.00%

    Dabrafenib-d9 (GSK2118436A-d9) es el deuterio etiquetado como Dabrafenib. Dabrafenib (GSK2118436A) es un inhibidor de Raf competitivo con ATP con IC50 de 5 nM y 0,6 nM para C-Raf y B-RafV600E, respectivamente.

  • GC47237 structure
    GC47237Dipyridamole-d16
    CAS: 2712261-50-0
    Purity: >99.00%

    A neuropeptide with diverse biological activities

  • GC47771 structure
    GC47771NG 25 (hydrochloride hydrate)
    Purity: >98.00%

    An inhibitor of MAP4K2 and TAK1

  • GC47931 structure
    GC47931PDE4B Inhibitor
    CAS: 2410550-31-9
    Purity: >98.00%

    A PDE4B inhibitor

  • GC48329 structure
    GC48329PKA Inhibitor (5-24) (trifluoroacetate salt)
    Purity: >95.00%

    A synthetic peptide inhibitor of PKA

  • GC48381 structure
    GC483815'-pApA (sodium salt)
    Purity: >95.00%

    A linearized form of cyclic di-AMP